STAG2 regulates interferon signaling in melanoma via enhancer loop reprogramming
Zhaowei Chu(Second Affiliated Hospital of Xi'an Jiaotong University), Bin Zheng(Harvard University), Genevieve M. Boland(Harvard University), Man Huang(Boston Children's Hospital), Adriano Piris(Brigham and Women's Hospital), Keith T. Flaherty(Cancer Research Center), Che‐Hung Shen(Kaohsiung Medical University), Yeguang Hu(Harvard University), Songmei Geng(Second Affiliated Hospital of Xi'an Jiaotong University), Toshimi Yoshida(Harvard University), Dennie T. Frederick(Broad Institute), Yang Shi(Wuhan University), Li Cai(Harvard University), Yifeng Qi(Lanzhou University), Da Teng(Anhui Medical University), Austin Y. Feng(Neurological Surgery), Emma Specht(Massachusetts General Hospital), Xiaoyang Zhang(University of Utah), Jiajia Chen(Dana-Farber Cancer Institute), Man Li(Second Affiliated Hospital of Jilin University), David Liu(University of Louisville), Lei Gu(Max Planck Institute for Heart and Lung Research), Katia Georgopoulos(Harvard University), Zhixin Niu(Max Planck Institute for Heart and Lung Research), Ryan J. Sullivan(Dana-Farber Cancer Institute)
Cited by 45
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
|New England Journal of Medicine|2010|3.5k
Genomic Classification of Cutaneous Melanoma
|Cell|2015|3.3k